Skip to main content

Twist Bioscience Corp

For the period ended Feb 5, 2026. Filed Jan 6, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Feb 5, 2026 · Filed Jan 6, 2026

Use the contents to explore the available documents and sections.

TWST$120.79+0.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Proxy Access

In 2022, our Board amended our bylaws to permit a stockholder, or group of up to 20 stockholders, owning

in the aggregate at least 3% of our outstanding common stock continuously for at least three years and who

continue to own such minimum shares through the date of the Annual Meeting, to nominate and include in our

proxy materials director nominees constituting up to the greater of two individuals or 20% of the Board of

Directors, provided that the nominating holders and the nominees satisfy the requirements specified in the

bylaws, including providing us with advance notice of the nomination.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.